Zoloperone

This classification denotes an anxiolytic with the molecular formula C22H24FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3YU9TET43B, chemically known as 2(3h)-oxazolone, 4-(4-fluorophenyl)-5-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)- but generally known as zoloperone, which bears US NIH Compound Identifier 68696. European Medicines Agency schedules Zoloperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00182MIG. The term ZOLOPERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). ZOLOPERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zoloperone under HS 29349990 and SITC 51579. As of Q4 2014, ZOLOPERONE remains the US FDA Preferred Term for this commodity. Zoloperone bears US NLM identifiers UMLS ID C1883610 and NCI Concept Code C66707. SMILES: FC1CCC(C2[NH]C(=O)OC2CCN2CCN(CC2)C2C(OC)CCCC2)CC1.